1qiv
From Proteopedia
(Difference between revisions)
m (Protected "1qiv" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
[[Image:1qiv.png|left|200px]] | [[Image:1qiv.png|left|200px]] | ||
- | <!-- | ||
- | The line below this paragraph, containing "STRUCTURE_1qiv", creates the "Structure Box" on the page. | ||
- | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
- | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
- | or leave the SCENE parameter empty for the default display. | ||
- | --> | ||
{{STRUCTURE_1qiv| PDB=1qiv | SCENE= }} | {{STRUCTURE_1qiv| PDB=1qiv | SCENE= }} | ||
===CALMODULIN COMPLEXED WITH N-(3,3,-DIPHENYLPROPYL)-N'-[1-R-(3,4-BIS-BUTOXYPHENYL)-ETHYL]-PROPYLENEDIAMINE (DPD), 1:2 COMPLEX=== | ===CALMODULIN COMPLEXED WITH N-(3,3,-DIPHENYLPROPYL)-N'-[1-R-(3,4-BIS-BUTOXYPHENYL)-ETHYL]-PROPYLENEDIAMINE (DPD), 1:2 COMPLEX=== | ||
- | |||
- | <!-- | ||
- | The line below this paragraph, {{ABSTRACT_PUBMED_10731425}}, adds the Publication Abstract to the page | ||
- | (as it appears on PubMed at http://www.pubmed.gov), where 10731425 is the PubMed ID number. | ||
- | --> | ||
{{ABSTRACT_PUBMED_10731425}} | {{ABSTRACT_PUBMED_10731425}} | ||
Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
- | *[[Calmodulin]] | + | *[[Calmodulin|Calmodulin]] |
==Reference== | ==Reference== | ||
- | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:010731425</ref><ref group="xtra">PMID:009799490</ref><ref group="xtra">PMID:007634090</ref><ref group="xtra">PMID:007803388</ref><references group="xtra"/> |
[[Category: Bos taurus]] | [[Category: Bos taurus]] | ||
[[Category: Bocskei, Z S.]] | [[Category: Bocskei, Z S.]] |
Revision as of 11:48, 26 July 2012
Contents |
CALMODULIN COMPLEXED WITH N-(3,3,-DIPHENYLPROPYL)-N'-[1-R-(3,4-BIS-BUTOXYPHENYL)-ETHYL]-PROPYLENEDIAMINE (DPD), 1:2 COMPLEX
Template:ABSTRACT PUBMED 10731425
About this Structure
1qiv is a 1 chain structure of Calmodulin with sequence from Bos taurus. Full crystallographic information is available from OCA.
See Also
Reference
- Harmat V, Bocskei Z, Naray-Szabo G, Bata I, Csutor AS, Hermecz I, Aranyi P, Szabo B, Liliom K, Vertessy BG, Ovadi J. A new potent calmodulin antagonist with arylalkylamine structure: crystallographic, spectroscopic and functional studies. J Mol Biol. 2000 Mar 31;297(3):747-55. PMID:10731425 doi:10.1006/jmbi.2000.3607
- Vertessy BG, Harmat V, Bocskei Z, Naray-Szabo G, Orosz F, Ovadi J. Simultaneous binding of drugs with different chemical structures to Ca2+-calmodulin: crystallographic and spectroscopic studies. Biochemistry. 1998 Nov 3;37(44):15300-10. PMID:9799490 doi:10.1021/bi980795a
- Vandonselaar M, Hickie RA, Quail JW, Delbaere LT. Trifluoperazine-induced conformational change in Ca(2+)-calmodulin. Nat Struct Biol. 1994 Nov;1(11):795-801. PMID:7634090
- Cook WJ, Walter LJ, Walter MR. Drug binding by calmodulin: crystal structure of a calmodulin-trifluoperazine complex. Biochemistry. 1994 Dec 27;33(51):15259-65. PMID:7803388